Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Weinstein

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Endocrine|December 16, 2011
Glucocorticoid-induced osteonecrosisRobert S Weinstein
Nature Clinical Practice. Endocrinology & Metabolism|January 24, 2007
Is long-term glucocorticoid therapy associated with a high prevalence of asymptomatic vertebral fractures?Robert S Weinstein
Bone|July 14, 2009
Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularityRobert S Weinstein
Endocrinology and Metabolism Clinics of North America|August 11, 2012
Glucocorticoid-induced osteoporosis and osteonecrosisRobert S Weinstein
The New England Journal of Medicine|July 8, 2011
Clinical practice. Glucocorticoid-induced bone diseaseRobert S Weinstein
Nature Reviews. Rheumatology|June 4, 2009
Giant osteoclasts after long-term bisphosphonate therapy: diagnostic challengesNidhi Jain, Robert S Weinstein
Bone|November 23, 2019
Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: A review of the role of ironLakshmi P Menon, Robert S Weinstein
Bone|December 15, 2012
Osteocyte apoptosisRobert L Jilka, Brendon Noble, Robert S Weinstein
The New England Journal of Medicine|January 2, 2009
Giant osteoclast formation and long-term oral bisphosphonate therapyRobert S Weinstein, Paula K Roberson, Stavros C Manolagas
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2007
Quantifying osteoblast and osteocyte apoptosis: challenges and rewardsRobert L Jilka, Robert S Weinstein, A Michael Parfitt, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Endocrine|December 16, 2011
Glucocorticoid-induced osteonecrosisRobert S Weinstein
Nature Clinical Practice. Endocrinology & Metabolism|January 24, 2007
Is long-term glucocorticoid therapy associated with a high prevalence of asymptomatic vertebral fractures?Robert S Weinstein
Bone|July 14, 2009
Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularityRobert S Weinstein
Endocrinology and Metabolism Clinics of North America|August 11, 2012
Glucocorticoid-induced osteoporosis and osteonecrosisRobert S Weinstein
The New England Journal of Medicine|July 8, 2011
Clinical practice. Glucocorticoid-induced bone diseaseRobert S Weinstein
Nature Reviews. Rheumatology|June 4, 2009
Giant osteoclasts after long-term bisphosphonate therapy: diagnostic challengesNidhi Jain, Robert S Weinstein
Bone|November 23, 2019
Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: A review of the role of ironLakshmi P Menon, Robert S Weinstein
Bone|December 15, 2012
Osteocyte apoptosisRobert L Jilka, Brendon Noble, Robert S Weinstein
The New England Journal of Medicine|January 2, 2009
Giant osteoclast formation and long-term oral bisphosphonate therapyRobert S Weinstein, Paula K Roberson, Stavros C Manolagas
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2007
Quantifying osteoblast and osteocyte apoptosis: challenges and rewardsRobert L Jilka, Robert S Weinstein, A Michael Parfitt, et al.
Pageof 6